ADVANCED UROTHELIAL CARCINOMA
Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to test new pill for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people to test a new oral drug called FX-909. The main goals are to find a safe dose and see how well the body handles it, both alone and when combined with an existing immunotherapy drug (pembrolizumab). It is for adults with advanced solid tumors, inc…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Two-Drug attack on tough bladder cancer shows promise
Disease control Recruiting nowThis study is testing whether a new drug, either alone or combined with an immunotherapy drug, can help control advanced bladder cancer that has spread and has a specific marker called HER2. It will involve about 96 adults whose cancer has progressed despite prior treatments. The…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New combo therapy aims to control advanced bladder cancer
Disease control Recruiting nowThis study is testing a two-part treatment for advanced bladder cancer that has spread. First, patients receive a combination of two drugs for about 4 months. If the cancer responds well, they then continue with just one of the drugs as a long-term 'maintenance' therapy for up to…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC